메뉴 건너뛰기




Volumn 54, Issue 3, 2006, Pages 549-550

Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? [7]

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; TRAZODONE;

EID: 33644653236     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00643_4.x     Document Type: Letter
Times cited : (35)

References (7)
  • 1
    • 1542350630 scopus 로고    scopus 로고
    • NIH Consensus Statement on Management of Hepatitis C: 2002
    • NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 2002 19 1 46
    • (2002) NIH Consens State Sci Statements , vol.19 , pp. 1-46
  • 2
    • 0027257453 scopus 로고
    • The use of recombinant interferon alpha-2b in elderly patients with anti-HCV-positive chronic active hepatitis
    • Bresci G Del Corso L Romanelli AM et al The use of recombinant interferon alpha-2b in elderly patients with anti-HCV-positive chronic active hepatitis J Am Geriatr Soc 1993 41 857 862
    • (1993) J Am Geriatr Soc , vol.41 , pp. 857-862
    • Bresci, G.1    Del Corso, L.2    Romanelli, A.M.3
  • 4
    • 0028998070 scopus 로고
    • Interferon therapy for patients more than 60 years of age with chronic hepatitis C
    • Horiike N Masumoto T Nakanishi K et al Interferon therapy for patients more than 60 years of age with chronic hepatitis C J Gastroenterol Hepatol 1995 10 246 249
    • (1995) J Gastroenterol Hepatol , vol.10 , pp. 246-249
    • Horiike, N.1    Masumoto, T.2    Nakanishi, K.3
  • 5
    • 20444447658 scopus 로고    scopus 로고
    • Long-term follow-up of interferon monotherapy in 454 consecutive naïve patients infected with hepatitis C virus
    • Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival
    • Akuta N Suzuki F Suzuki Y et al Long-term follow-up of interferon monotherapy in 454 consecutive naïve patients infected with hepatitis C virus Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival Scand J Gastroenterol 2005 40 688 696
    • (2005) Scand J Gastroenterol , vol.40 , pp. 688-696
    • Akuta, N.1    Suzuki, F.2    Suzuki, Y.3
  • 6
    • 17044427118 scopus 로고    scopus 로고
    • Prevention of hepatocellular carcinoma
    • Craxì A Cammà L. Prevention of hepatocellular carcinoma Clin Liver Dis 2005 9 329 346
    • (2005) Clin Liver Dis , vol.9 , pp. 329-346
    • Craxì, A.1    Cammà, L.2
  • 7
    • 28044445876 scopus 로고    scopus 로고
    • Hepatitis C in patients 65 years or older. a severe and neglected curable disease?
    • (Abstract)
    • Thabut D Le Calvez S Thibault V et al Hepatitis C in patients 65 years or older. A severe and neglected curable disease? Hepatology 2003 38 (Suppl. 1) 424A (Abstract)
    • (2003) Hepatology , vol.381
    • Thabut, D.1    Le Calvez, S.2    Thibault, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.